![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/19 | (2006.01) |
A61K 31/00 | (2013.01) | ||
A61K 47/10 | (2017.01) | ||
A61K 9/19 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/175 | (2013.01) | ||
A61K 31/17 | (2006.01) | ||
A61K 47/10 | (2013.01) | ||
A61K 31/175 | (2006.01) | ||
A61P 19/00 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 35/00 | (2018.01) |
(11) | Patento numeris | 3218061 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15859861.5 |
Europos patento paraiškos padavimo data | 2015-11-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-09-20 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-29 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2015/060052 |
Data | 2015-11-11 |
(87) | Numeris | WO 2016/077406 |
Data | 2016-05-19 |
(30) | Numeris | Data | Šalis |
201462080091 P | 2014-11-14 | US | |
201514936227 | 2015-11-09 | US |
(72) |
PATEL, Mahendra R. , US
|
(73) |
Navinta III Inc ,
1003 Clint Moore Road, Boca Raton, FL 33487,
US
|
(54) | CARMUSTINE PHARMACEUTICAL COMPOSITION |
CARMUSTINE PHARMACEUTICAL COMPOSITION |